|Print Page | Close Window|
|May 23, 2018 - 4:02 p.m.|
Gilead Sciences to Present at the Jefferies 2018 Healthcare Conference on Wednesday, June 6
|May 15, 2018 - 10:58 a.m.|
U.S. Food and Drug Administration Approves Expanded Indication for Truvada® (Emtricitabine and Tenofovir Disoproxil Fumarate) for Reducing the Risk of Acquiring HIV-1 in Adolescents
Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.